Ben Tran (@drbentran) 's Twitter Profile
Ben Tran

@drbentran

Medical Oncologist with research interests in urological cancers, early drug development and real world data. Also a really nice guy!

ID: 771702379557232640

calendar_today02-09-2016 13:32:39

53 Tweet

481 Followers

87 Following

Sant-Rayn Pasricha (@srpasricha) 's Twitter Profile Photo

On behalf of WEHI (Walter and Eliza Hall Institute) & @TRUECOM1 we’re pleased to share the results of the #REVAMP trial comparing ferric carboxymaltose (#FCM) with oral #iron to treat antenatal #anaemia in pregnant Malawian Women just out in The Lancet. thelancet.com/journals/lance…

Ciara Conduit (@ciaraconduit) 's Twitter Profile Photo

So pleased to see our paper evaluating patterns of Relapse in Patients With Stage 1 #TesticularCancer: Utility of ANZUP Surveillance Recommendations in print JCO Oncology Practice over the weekend - ascopubs.org/doi/10.1200/OP… Ben Tran

Prof Ananya💙 @achoud72.bsky.social (@achoud72) 's Twitter Profile Photo

Alex Wyatt describes the breadth of heterogeneity in local prostate cancer. It's almost impossible to predict which genotype belongs to the dominant clone. Should we combine samples?🤔 #ANZUP23 ANZUP Renu Eapen Ben Tran Ian Davis (Bluesky @profiand)

<a href="/ResearchWyatt/">Alex Wyatt</a> describes the breadth of heterogeneity in local prostate cancer. It's almost impossible to predict which genotype belongs to the dominant clone. Should we combine samples?🤔 #ANZUP23 <a href="/ANZUPtrials/">ANZUP</a> <a href="/RenuEapen/">Renu Eapen</a> <a href="/DrBenTran/">Ben Tran</a> <a href="/Prof_IanD/">Ian Davis (Bluesky @profiand)</a>
the limbic (@thelimbiconc) 's Twitter Profile Photo

SIGN UP: bit.ly/3DBToRT Our upcoming webinar hosted by David Pook features the best in GU oncology! Join our experts as they analyse the key insights from #ASCO23 & discuss implications for Australian practice. Panel: Ben Tran Chun Loo Gan & Dr Tania Moujaber

Cancer Council NSW (@ccnewsouthwales) 's Twitter Profile Photo

You may not hear of testicular cancer as much as others, but did you know males aged 20-39 are the most commonly diagnosed? Download our Understanding Testicular Cancer booklet 👉 ow.ly/4xc250PTKxH With thanks to Ben Tran, Nariman Ahmadi and Chris O’Brien Lifehouse

You may not hear of testicular cancer as much as others, but did you know males aged 20-39 are the most commonly diagnosed?

Download our Understanding Testicular Cancer booklet 👉 ow.ly/4xc250PTKxH

With thanks to <a href="/DrBenTran/">Ben Tran</a>, <a href="/NarimanAhmadi/">Nariman Ahmadi</a> and <a href="/COBLH/">Chris O’Brien Lifehouse</a>
Cancer Discovery (@cd_aacr) 's Twitter Profile Photo

Just published with the #AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell #Carcinoma, by Sumanta K. Pal, MD, FASCO et al. bit.ly/3J5jzTH City of Hope AACR

Just published with the #AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell #Carcinoma, by <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> et al.
bit.ly/3J5jzTH
<a href="/cityofhope/">City of Hope</a> <a href="/AACR/">AACR</a>
GU Cast | Urology podcast! (@gu_onc) 's Twitter Profile Photo

Three big things in testis cancer! Great GU Cast with testis cancer gurus Rob Hamilton Ben Tran while up at #ANZUP24 ASM recently. Timely overview of some important areas of progress in testis cancer Renu Eapen Declan Murphy youtu.be/Pze6B_B58E8?si…

Raffaele Colombo (@raffcolo) 's Twitter Profile Photo

Ben Tran late breaking presentation of TYRA-300, a selective FGFR3 inhibitors in patients with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) at EORTC National Cancer Institute AACR #ENASymp24

<a href="/DrBenTran/">Ben Tran</a> late breaking presentation of TYRA-300, a selective FGFR3 inhibitors in patients with advanced solid tumors with activating FGFR3 mutations/fusions (SURF301) at <a href="/EORTC/">EORTC</a> <a href="/theNCI/">National Cancer Institute</a> <a href="/AACR/">AACR</a> #ENASymp24